Finnrick - Ensuring a Safer and More Transparent Supply Chain
Verified Peptides

Verified Peptides

Ipamorelin

Finnrick tested 5 samples of Ipamorelin (GHS agonist) from Verified Peptides between 13 Feb 2025 and 28 Apr 2026. Test scores average over 5, no score below 4, and at least 2 tests warrant a tentative Finnrick Rating of C (Okay).

Finnrick Rating™
Tentative Rating
Verified Peptides
Ipamorelin
Tested 5 Samples
Last test 28 Apr 2026

Take Action

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

All Ipamorelin tests from Verified Peptides

Samples are tested in commercial labs

Tests Count

5

Scores

AVG6.1MIN4.9MAX7.9

Last

28 Apr 2026

First

13 Feb 2025
Quantity
Test DateCertificate
Test Score
Label
Batch
TestedDifferencePurityEndotoxinsBatch IDContainerTested AtSent By
28 Apr 2026View7.910mg(no batch claim)11.3mg+13.0%99.90%
low
TM03260820HPurple Label / Silver Crimp / Black CapLab EPublic
19 Feb 2025View6.95mg
5.6mg
5.31mg-5.5%99.03%n/a07-24-050SECopper Label /Silver Crimp / Yellow CapLab AFinnrick
19 Feb 2025View4.95mg
5.6mg
6.6mg+17.4%99.27%n/a07-24-050SECopper Label /Silver Crimp / Yellow CapLab BFinnrick
13 Feb 2025View5.35mg
5.6mg
4.85mg-13.7%99.25%n/a07-24-050SECopper Label /Silver Crimp / Yellow CapLab CFinnrick
13 Feb 2025View5.55mg
5.6mg
4.93mg-12.3%99.24%n/a07-24-050SECopper Label /Silver Crimp / Yellow CapLab CFinnrick